<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2019-11-200-204</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-3104</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ТРУДНЫЙ ДИАГНОЗ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>DIFFICULT DIAGNOSIS</subject></subj-group></article-categories><title-group><article-title>Особенности питания детей раннего возраста с онкологическими заболеваниями в процессе противоопухолевого лечения</article-title><trans-title-group xml:lang="en"><trans-title>Nutrition features of young children with oncological diseases in the process of antitumor treatment</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вашура</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Vashura</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Вашура Андрей Юрьевич – кандидат медицинских наук, врачдиетолог, заведующий отделом научных основ питания и нутритивно-метаболической терапии лечебно-реабилитационного научного центра «Русское поле»</p><p>142321, Московская обл., Чеховский район, СП Стремиловское, дер. Гришенки </p></bio><bio xml:lang="en"><p>Vashura Andrey Yurievich – Cand. of Sci. (Med), Nutritionist, Head of the Department of Scientific Basics of Nutrition and Nutritive Metabolic Therapy of the Medical and Rehabilitation Research Center «Russian Field»</p><p>142321, Moscow region, Chekhovskiy district, Stremilovskoye, Grishenki village </p></bio><email xlink:type="simple">avashura@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алымова</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Alymova</surname><given-names>Ju. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алымова Юлия Александровна – врач-педиатр отдела нутритивной поддержки</p><p>117198, г. Москва, ул. Саморы Машела, д. 1. </p></bio><bio xml:lang="en"><p>Alymova Julia Aleksandrovna – Pediatrician of the Department of Nutritional Support</p><p>117198, Moscow, Samory Mashela St., 1 </p></bio><email xlink:type="simple">yu.al.meln@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федерального государственного бюджетного учреждения «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии имени Дмитрия Рогачева» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budgetary Institution «National Medical Research Center of Children’s Hematology, Oncology and Immunology named after Dmitry Rogachev» of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии имени Дмитрия Рогачева» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budgetary Institution «National Medical Research Center of Children’s Hematology, Oncology and Immunology named after Dmitry Rogachev» of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>18</day><month>07</month><year>2019</year></pub-date><volume>0</volume><issue>11</issue><fpage>200</fpage><lpage>204</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Вашура А.Ю., Алымова Ю.А., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Вашура А.Ю., Алымова Ю.А.</copyright-holder><copyright-holder xml:lang="en">Vashura A.Y., Alymova J.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/3104">https://www.med-sovet.pro/jour/article/view/3104</self-uri><abstract><p>Проведение противоопухолевого лечения детей с онкологическими заболеваниями часто сопровождается многими осложнениями, одно из самых существенных – нарушения питания. Эти нарушения могут усугублять уже имеющиеся проблемы, усложнять лечение пациента и часто диктуют необходимость специальной организации его питания. В первую очередь она базируется на ограничениях, связанных с требованиями к низкомикробности пищи (в связи с резко сниженным иммунитетом), гастроинтестинальными нарушениями различной тяжести и распространенности, особенностями вкусовосприятия и аппетита ребенка (которые почти всегда нарушаются в процессе противоопухолевой терапии), а также психологическими проблемами. У детей раннего возраста эта ситуация весьма существенна, поскольку осложнения, особенно гастроинтестинальные, могут сохраняться длительно, что может ограничивать развитие ребенка даже при успешном завершении основного лечения или вовсе препятствовать ему. Поэтому такие пациенты нуждаются в проведении специальной нутритивной поддержки: энтеральном и нередко парентеральном питании, а также в особом подходе к диете, основу которой часто составляют продукты детского питания промышленного производства.</p></abstract><trans-abstract xml:lang="en"><p>Carrying out antitumor treatment of children with oncological diseases is often accompanied by many complications, one of the most significant eating disorders. These disorders can aggravate the existing problems, complicate the patient’s treatment and often dictate the need for special nutritional support. First of all, it is based on the limitations associated with the requirements for low microbial density of food (due to sharply reduced immunity), gastrointestinal disorders of varying severity and prevalence, peculiarities of taste and appetite of the child (which are almost always violated in the process of antitumor therapy), as well as psychological problems. In children of early age, this situation is very significant, since complications (especially gastrointestinal complications) can last for a long time, which may limit the development of the child, even if the basic treatment is successfully completed, or even prevent him or her from developing at all. Therefore, such patients need special nutritional support: enteral and often parenteral nutrition, as well as a special approach to diet, which is often based on industrial baby food products.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Ключевые слова: онкология</kwd><kwd>дети</kwd><kwd>ранний возраст</kwd><kwd>питание</kwd><kwd>нутритивная поддержка</kwd></kwd-group><kwd-group xml:lang="en"><kwd>oncology</kwd><kwd>children</kwd><kwd>early age</kwd><kwd>nutrition</kwd><kwd>nutritional support</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Fearon K.C., Voss A.C., Hustead D.S. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006;83:1345–50.</mixed-citation><mixed-citation xml:lang="en">Fearon K.C., Voss A.C., Hustead D.S. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr. 2006;83:1345–50.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Arpaci T., Toruner E.K., Altay N. Assessment of Nutritional Problems in Pediatric Patients with Cancer and the Information Needs of Their Parents: A Parental Perspective. Asia Pac J Oncol Nurs. 2018 Apr-Jun;5(2):231-236.</mixed-citation><mixed-citation xml:lang="en">Arpaci T., Toruner E.K., Altay N. Assessment of Nutritional Problems in Pediatric Patients with Cancer and the Information Needs of Their Parents: A Parental Perspective. Asia Pac J Oncol Nurs. 2018 Apr-Jun;5(2):231-236.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Barber M.D. The pathophysiology and treatment of cancer cachexia. Nutr Clin Pract. 2002(17):203–9.</mixed-citation><mixed-citation xml:lang="en">Barber M.D. The pathophysiology and treatment of cancer cachexia. Nutr Clin Pract. 2002(17):203–9.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Withycombe J.S., Smith L.M., Meza J.L., Merkle C., Faulkner M.S., Ritter L., Seibel N.L., Moore K. Weight change during childhood acute lymphoblastic leukemia induction therapy predicts obesity: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2015;62:434–9.</mixed-citation><mixed-citation xml:lang="en">Withycombe J.S., Smith L.M., Meza J.L., Merkle C., Faulkner M.S., Ritter L., Seibel N.L., Moore K. Weight change during childhood acute lymphoblastic leukemia induction therapy predicts obesity: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2015;62:434–9.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Romero-Corral A., Somers V.K., Sierra-Johnson J., Korenfeld Y., Boarin S., Korinek J., Jensen M.D., Parati G., Lopez-Jimenez F. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J. 2010 Mar;31(6):737-46.</mixed-citation><mixed-citation xml:lang="en">Romero-Corral A., Somers V.K., Sierra-Johnson J., Korenfeld Y., Boarin S., Korinek J., Jensen M.D., Parati G., Lopez-Jimenez F. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J. 2010 Mar;31(6):737-46.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ward P.S., Thompson C.B. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell. 2012;21:297–308.</mixed-citation><mixed-citation xml:lang="en">Ward P.S., Thompson C.B. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell. 2012;21:297–308.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Onesti J.K., Guttridge D.C. Inflammation based regulation of cancer cachexia. Biomed Res Int. 2014;2014:168407</mixed-citation><mixed-citation xml:lang="en">Onesti J.K., Guttridge D.C. Inflammation based regulation of cancer cachexia. Biomed Res Int. 2014;2014:168407</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Livshits Z., Rao R.B., Smith S.W. An approach to chemotherapy-associated toxicity. Emerg Med Clin North Am. 2014 Feb;32(1):167-203. doi: 10.1016/j.emc.2013.09.002.</mixed-citation><mixed-citation xml:lang="en">Livshits Z., Rao R.B., Smith S.W. An approach to chemotherapy-associated toxicity. Emerg Med Clin North Am. 2014 Feb;32(1):167-203. doi: 10.1016/j.emc.2013.09.002.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Schcolnik-Cabrera A., Chavez-Blanco A., Dominguez-Gomez G., Duenas-Gonzalez A. Understanding tumor anabolism and patient catabolism in cancer-associated cachexia. Am J Cancer Res. 2017 May 1;7(5):1107-1135.</mixed-citation><mixed-citation xml:lang="en">Schcolnik-Cabrera A., Chavez-Blanco A., Dominguez-Gomez G., Duenas-Gonzalez A. Understanding tumor anabolism and patient catabolism in cancer-associated cachexia. Am J Cancer Res. 2017 May 1;7(5):1107-1135.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bing C., Trayhurn P. Regulation of adipose tissue metabolism in cancer cachexia. Curr Opin Clin Nutr Metab Care. 2008;11:201–207.</mixed-citation><mixed-citation xml:lang="en">Bing C., Trayhurn P. Regulation of adipose tissue metabolism in cancer cachexia. Curr Opin Clin Nutr Metab Care. 2008;11:201–207.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Esper D.H., Harb W.A. The cancer cachexia syndrome: a review of metabolic and clinical manifestations. Nutr Clin Pract. 2005;20:369– 376.</mixed-citation><mixed-citation xml:lang="en">Esper D.H., Harb W.A. The cancer cachexia syndrome: a review of metabolic and clinical manifestations. Nutr Clin Pract. 2005;20:369– 376.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Curra M., Soares Junior L.A.V., Martins M.D., Santos P.S.D.S. Chemotherapy protocols and incidence of oral mucositis. An integrative review. Einstein (Sao Paulo). 2018;16(1):eRW4007.</mixed-citation><mixed-citation xml:lang="en">Curra M., Soares Junior L.A.V., Martins M.D., Santos P.S.D.S. Chemotherapy protocols and incidence of oral mucositis. An integrative review. Einstein (Sao Paulo). 2018;16(1):eRW4007.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Brinksma A., Huizinga G., Sulkers E., et al. Malnutrition in childhood cancer patients: A review on its prevalence and possible causes. Critical Reviews in Oncology / Hematology. 2012;83:249-275.</mixed-citation><mixed-citation xml:lang="en">Brinksma A., Huizinga G., Sulkers E., et al. Malnutrition in childhood cancer patients: A review on its prevalence and possible causes. Critical Reviews in Oncology / Hematology. 2012;83:249-275.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Wedrychowicz A., Spodaryk M., KrasowskaKwiecień A., Goździk J. Total parenteral nutrition in children and adolescents treated with high-dose chemotherapy followed by autologous haematopoietic transplants. Br J Nutr. 2010 Mar;103(6):899–906.</mixed-citation><mixed-citation xml:lang="en">Wedrychowicz A., Spodaryk M., KrasowskaKwiecień A., Goździk J. Total parenteral nutrition in children and adolescents treated with high-dose chemotherapy followed by autologous haematopoietic transplants. Br J Nutr. 2010 Mar;103(6):899–906.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
